Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rawel XL 1.5mg tablets
0202010P0BLAAAD
|
Rawel XL | Indapamide | Cardiovascular System | 15 |
|
Amlodipine 10mg/5ml oral liquid
0206020A0AAADAD
|
Amlodipine | Amlodipine | Cardiovascular System | 14 |
|
Lisinopril 5mg/5ml oral liquid
0205051L0AAAGAG
|
Lisinopril | Lisinopril | Cardiovascular System | 14 |
|
Nadolol 30mg/5ml oral suspension
0204000M0AAAIAI
|
Nadolol | Nadolol | Cardiovascular System | 14 |
|
Nifedipress MR 10 tablets (Teva)
0206020R0CBACAE
|
Nifedipress | Nifedipine | Cardiovascular System | 14 |
|
Hydralazine 10mg tablets
0205010J0AABKBK
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | 13 |
|
Lopid 300mg capsules
0212000Q0BBAAAA
|
Lopid | Gemfibrozil | Cardiovascular System | 13 |
|
Torem 10mg tablets
0202020U0BBACAC
|
Torem | Torasemide | Cardiovascular System | 13 |
|
Accuretic 10mg/12.5mg tablets
0205051P0BBAAAA
|
Accuretic | Quinapril hydrochloride with diuretic | Cardiovascular System | 12 |
|
Catapres TTS 1 patches
0205020E0BBAEAF
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 12 |
|
Irbesartan 150mg/5ml oral suspension
0205052I0AAAFAF
|
Irbesartan | Irbesartan | Cardiovascular System | 12 |
|
Lisoretic 10mg/12.5mg tablets
0205051K0BFABAB
|
Lisoretic | Lisinopril with diuretic | Cardiovascular System | 12 |
|
Opilon 40mg tablets
0206040AIBBAAAC
|
Opilon | Moxisylyte hydrochloride | Cardiovascular System | 12 |
|
Pinefeld XL 10mg tablets
0206020F0BMAAAC
|
Pinefeld | Felodipine | Cardiovascular System | 12 |
|
Simvador 80mg tablets
0212000Y0BDADAH
|
Simvador | Simvastatin | Cardiovascular System | 12 |
|
Valsartan 3mg/ml oral solution
0205052V0AAAJAJ
|
Valsartan | Valsartan | Cardiovascular System | 12 |
|
Aqumeldi 0.25mg orodispersible tablets
0205051I0BFAACC
|
Aqumeldi | Enalapril maleate | Cardiovascular System | 11 |
|
Dilcardia SR 60mg capsules
0206020C0BPACAJ
|
Dilcardia | Diltiazem hydrochloride | Cardiovascular System | 11 |
|
Diltiazem 60mg/5ml oral solution
0206020C0AAARAR
|
Diltiazem hydrochloride | Diltiazem hydrochloride | Cardiovascular System | 11 |
|
Heparin sodium 1,000units/1ml inj ampoules
0208010K0AAA7A7
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | 11 |
|
Ifirmasta 75mg tablets
0205052I0BEAAAA
|
Ifirmasta | Irbesartan | Cardiovascular System | 11 |
|
Innohep 8,000units/0.4ml inj pre-filled syringes
0208010W0BCANAT
|
Innohep | Tinzaparin sodium | Cardiovascular System | 11 |
|
Isosorbide dinitrate 5mg tablets
0206010I0AAAKAK
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | 11 |
|
Revatio 20mg tablets
0205010Y0BBAAAA
|
Revatio | Sildenafil(Vasodilator Antihypertensive) | Cardiovascular System | 11 |
|
Atorvastatin 10mg/5ml oral suspension
0212000B0AAARAR
|
Atorvastatin | Atorvastatin | Cardiovascular System | 10 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.